pembrolizumab

pembrolizumab is a topic covered in the Davis's Drug Guide.

To view the entire topic, please or .

Medicine Central™ is a quick-consult mobile and web resource that includes diagnosis, treatment, medications, and follow-up information on over 700 diseases and disorders, providing fast answers—anytime, anywhere. Explore these free sample topics:

-- The first section of this topic is shown below --

General

Genetic Implications: Genetic Implications

Pronunciation:
pem-broe-li-zoo-mab


Trade Name(s)

  • Keytruda

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies
programmed death-1 inhibitors

-- To view the remaining sections of this topic, please or --

General

Genetic Implications: Genetic Implications

Pronunciation:
pem-broe-li-zoo-mab


Trade Name(s)

  • Keytruda

Ther. Class.
antineoplastics

Pharm. Class.
monoclonal antibodies
programmed death-1 inhibitors

There's more to see -- the rest of this entry is available only to subscribers.